Laceration Clinical Trial
Official title:
A Randomized, Controlled, Post-market Clinical Investigation to Evaluate Zip Surgical Skin Closure Device in Comparison of Using Standard of Care Sutures for Laceration Repair in Pediatrics and Adults in an Accident and Emergency Department
NCT number | NCT03199456 |
Other study ID # | Zip-009 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 16, 2017 |
Est. completion date | August 24, 2018 |
Verified date | September 2018 |
Source | ZipLine Medical Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Zip-009 clinical investigation will enroll 26 paediatric and adult subjects requiring laceration repair and fulfilling the eligibility criteria for the clinical investigation. The investigation is designed to evaluate the time and cost savings and the satisfaction and outcomes of the Zip device compared to conventional sutures. The subjects will be randomly assigned at a 1:1 ratio to either the Zip Surgical Skin Closure Device group or the Standard of Care sutures group. The investigation consists of one screening/baseline visits at day 0 where the subject will be treated with either the Zip device or sutures, and thereafter two follow up telephone calls at day 10 and day 30. The Zip device/sutures will be removed prior the first follow up call day 10. The duration of the investigation is estimated to 5 months, including a 4-month recruitment period and 1-month follow up period.
Status | Completed |
Enrollment | 26 |
Est. completion date | August 24, 2018 |
Est. primary completion date | July 25, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 4 Years and older |
Eligibility |
Inclusion Criteria: 1. Between 4 and above at the time of laceration repair. 2. Require suture closure as standard of care for simple straight wounds on trunk, extremities or face. 3. Low Tension Laceration, e.g. skin can be easily approximated by pinching with fingers. 4. Subject and legal representative(s) (if a pediatric subject) are willing and able to comply with the investigational device removal and meet the follow up requirements. 5. Subject and legal representative(s) (if a pediatric subject) have been informed of the nature, the scope and the relevance of the study. 6. Subject and legal representative(s) (if a pediatric subject) have voluntarily agreed to participation and have duly signed the Informed Consent Form. Exclusion Criteria: 1. Known personal or familial history of scar hypertrophy. 2. Known or suspected allergies or hypersensitivity to non-latex skin adhesives. 3. Atrophic skin deemed clinically prone to blistering. 4. Wounds that are easily susceptible to infection as a result of exposure to unsanitary conditions ("dirty wounds"). 5. Wounds that require deep dermal closure using sutures. 6. Known or suspected mental problems and/or aggressiveness that indicates that the subject might try to remove the device during the treatment period. 7. Ongoing treatment with cytostatic. 8. Known or suspected diagnosis of severe anorexia. 9. Participating in any other clinical investigation. 10. Known health condition that would affect healing in the opinion of the investigator. 11. Any subject that according to the Declaration of Helsinki is deemed unsuitable for study enrolment. |
Country | Name | City | State |
---|---|---|---|
Sweden | Funktionsområde Akut Huddinge, Akutmottagningen Huddinge, Karolinska Universitetssjukhuset | Huddinge | |
Sweden | Funktionsområde Akutsjukvård Barn Solna, Astrid Lindgrens Barnsjukhus, Karolinska Universitetssjukhuset | Stockholm |
Lead Sponsor | Collaborator |
---|---|
ZipLine Medical Inc. |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Incidence and severity of Adverse Events (AEs) | The incidence and severity of adverse events associated with the Zip Surgical Skin Closure Device and Standard of Care closure sutures. | 30 days (+/-2 days) | |
Primary | Treatment time | The primary endpoint in this clinical investigation is the mean difference in time to wound closure, for the two treatment methods used. These include total treatment time and duration of period starting from the preparation of procedure until protective wound dressing is applied, and including whether or not anesthesia and/or sedation was used when comparing the Zip Surgical Skin Closure Device and the standard of care closure suturing. | Day 0 | |
Secondary | Objective evaluation on photographs using Wound Evaluation Score (WES) | Difference in Wound Evaluation Score at 10 days and 30 days post-treatment compare to baseline when comparing scar satisfaction and appearance of the subjects receiving Zip Surgical Skin Closure Device versus Standard of Care closure suturing. The score will be based on digital photographs taken on day 0, day 10 and day 30 and made by an independent panel of blinded physician(s). | Day 0, Day 10 (+/- 2 days), Day 30 (+/- 2 days) | |
Secondary | Subject satisfaction | Rate of wound healing satisfaction in subject at 30 days post-treatment when comparing Zip Surgical Skin Closure Device versus Standard of Care closure suturing. The endpoint will utilize a questionnaire for the subject to fill out. | Day 30 (+/- 2 days) | |
Secondary | Visual Analog Scale (VAS) for pain | The level of pain in connection to device application and removal measured by a visual analog scale (VAS) 0-100 mm. | Day 0 and Day 10 (+/- 2 days) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03280628 -
Trial Comparing Cosmetic Outcomes of Pediatric Laceration Closure Using Skin Glue, Medical Tape Versus Stitches
|
N/A | |
Completed |
NCT00451724 -
Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair
|
Phase 2 | |
Completed |
NCT05240248 -
Optilene® Suture Material for Dermal Sutures
|
||
Completed |
NCT02882256 -
Video Discharge Instructions (VDI) as Adjuncts to Written Discharge Instructions in the Emergency Department
|
N/A | |
Active, not recruiting |
NCT02168439 -
Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair
|
Phase 4 | |
Completed |
NCT03080467 -
Long-Term Outcome of Pediatric Traumatic Wound Repair: Suture Versus Tissue Adhesive
|
||
Recruiting |
NCT05225714 -
Dermal Wound Closure Using Silkam®
|
||
Active, not recruiting |
NCT01911351 -
Nitrous Oxide Use in Minor Procedures
|
N/A | |
Suspended |
NCT01268670 -
The Addition of Oral Analgesics to LET During Laceration Repair
|
N/A | |
Recruiting |
NCT04557761 -
Comparison of microMend® Devices to Sutures in Closing Lacerations in Children
|
N/A | |
Completed |
NCT05812352 -
Supporting Laypeople Addressing Prehospital Hemorrhage Study
|
N/A | |
Completed |
NCT00834730 -
Comparison of N2O Inhalation and Ketamine in Pediatric PSA
|
Phase 4 | |
Completed |
NCT03053947 -
Pain Free Laceration Repairs Using Intra-nasal Ketamine
|
Phase 2 | |
Recruiting |
NCT03681717 -
Virtual Reality vs. Standard-of-Care for Comfort During Laceration Repair
|
N/A | |
Completed |
NCT03071601 -
Prospective Evaluation of Topical Analgesia for Laceration Repair in the Emergency Department
|
Phase 4 | |
Completed |
NCT06370910 -
Comparison Low-Level Laser Therapy With Cryotherapy in Parturients With Laceration and/or Episiotomy on Pain Reduction
|
N/A | |
Completed |
NCT05148390 -
Study to Examine Clinical Performance and Safety of Cutimed® Gelling Fiber in Routine Clinical Practice
|
||
Not yet recruiting |
NCT06217081 -
3M™ Topical Tissue Adhesive Versus Commercially Available Tissue Adhesive for the Closure of Lacerations and Incisions
|
N/A | |
Withdrawn |
NCT03499002 -
Teaching Medical Students How to Suture: Standard Simulation vs in Situ
|
N/A |